EY-Parthenon
PwC
EY-Parthenon is a
PwC has a dedicated health
fast-growing strategy
services, medtech and
consultancy, committed to
pharma deal team of more
bringing unconventional
than 100 people across the
yet pragmatic thinking to
UK. It supports clients in the
deliver actionable strategies
private and public sector
with real impact. With more
healthcare spaces, leveraging
than 1,500 consultants
its wealth of experience to
globally, EY-Parthenon has
provide robust, evidenced
grown rapidly over the past
and realisable views on key
five years. With healthcare
questions and areas of focus.
practices in the UK, US,
PwC works with clients, both
MENA and Asia-Pacific,
operators and investors,
EY-Parthenon offers global
across all the key healthcare
perspectives. The company
subsectors and supports on
represents a central pillar
acquisitions, divestments,
of EY’s transaction advisory
raising finance, developing
services proposition, through
strategy, embedding
which EY offers end-to-end
operational, regulatory and
connected capital solutions
quality excellence, driving
across the transaction
management reporting
life cycle. EY transaction
solutions, and data analytics.
ADVISORY & FINANCE Consultants of the year – transactional
Candesic CIL Management Consultants Connell Consulting EY-Parthenon PwC
advisory services offers lead advisory, valuations, transaction diligence, strategy and commercial diligence, restructuring, and tax services, providing a comprehensive proposition to unlock the greatest value for clients.
healthinvestor.co.uk
25
